These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23138527)

  • 1. Identification of COL6A2 mutations in progressive myoclonus epilepsy syndrome.
    Karkheiran S; Krebs CE; Makarov V; Nilipour Y; Hubert B; Darvish H; Frucht S; Shahidi GA; Buxbaum JD; Paisán-Ruiz C
    Hum Genet; 2013 Mar; 132(3):275-83. PubMed ID: 23138527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.
    Bassuk AG; Wallace RH; Buhr A; Buller AR; Afawi Z; Shimojo M; Miyata S; Chen S; Gonzalez-Alegre P; Griesbach HL; Wu S; Nashelsky M; Vladar EK; Antic D; Ferguson PJ; Cirak S; Voit T; Scott MP; Axelrod JD; Gurnett C; Daoud AS; Kivity S; Neufeld MY; Mazarib A; Straussberg R; Walid S; Korczyn AD; Slusarski DC; Berkovic SF; El-Shanti HI
    Am J Hum Genet; 2008 Nov; 83(5):572-81. PubMed ID: 18976727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A very rare form of autosomal dominant progressive myoclonus epilepsy caused by a novel variant in the PRICKLE1 gene.
    Algahtani H; Al-Hakami F; Al-Shehri M; Shirah B; Al-Qahtani MH; Abdulkareem AA; Naseer MI
    Seizure; 2019 Jul; 69():133-139. PubMed ID: 31035234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.
    Courage C; Oliver KL; Park EJ; Cameron JM; Grabińska KA; Muona M; Canafoglia L; Gambardella A; Said E; Afawi Z; Baykan B; Brandt C; di Bonaventura C; Chew HB; Criscuolo C; Dibbens LM; Castellotti B; Riguzzi P; Labate A; Filla A; Giallonardo AT; Berecki G; Jackson CB; Joensuu T; Damiano JA; Kivity S; Korczyn A; Palotie A; Striano P; Uccellini D; Giuliano L; Andermann E; Scheffer IE; Michelucci R; Bahlo M; Franceschetti S; Sessa WC; Berkovic SF; Lehesjoki AE
    Am J Hum Genet; 2021 Apr; 108(4):722-738. PubMed ID: 33798445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
    Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
    J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
    Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
    Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia.
    Corbett MA; Schwake M; Bahlo M; Dibbens LM; Lin M; Gandolfo LC; Vears DF; O'Sullivan JD; Robertson T; Bayly MA; Gardner AE; Vlaar AM; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Lehesjoki AE; Gecz J; Berkovic SF
    Am J Hum Genet; 2011 May; 88(5):657-63. PubMed ID: 21549339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous splice-site mutation in SCARB2 is associated with progressive myoclonic epilepsy with renal failure.
    Yari A; Ali-Nejad RM; Saleh-Gohari N
    Neurol Sci; 2021 Dec; 42(12):5077-5085. PubMed ID: 33772352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense variant in the LMNB2 gene causes progressive myoclonus epilepsy.
    Soleimanipour F; Razmara E; Rahbarizadeh F; Fallahi E; Khodaeian M; Tavasoli AR; Garshasbi M
    Acta Neurol Belg; 2022 Jun; 122(3):659-667. PubMed ID: 33783721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations.
    Fu YJ; Aida I; Tada M; Tada M; Toyoshima Y; Takeda S; Nakajima T; Naito H; Nishizawa M; Onodera O; Kakita A; Takahashi H
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):551-63. PubMed ID: 23659519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic variants in KCTD7 perturb neuronal K+ fluxes and glutamine transport.
    Moen MN; Fjær R; Hamdani EH; Laerdahl JK; Menchini RJ; Vigeland MD; Sheng Y; Undlien DE; Hassel B; Salih MA; El Khashab HY; Selmer KK; Chaudhry FA
    Brain; 2016 Dec; 139(Pt 12):3109-3120. PubMed ID: 27742667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
    Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
    Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.
    Hopfner F; Schormair B; Knauf F; Berthele A; Tölle TR; Baron R; Maier C; Treede RD; Binder A; Sommer C; Maihöfner C; Kunz W; Zimprich F; Heemann U; Pfeufer A; Näbauer M; Kääb S; Nowak B; Gieger C; Lichtner P; Trenkwalder C; Oexle K; Winkelmann J
    BMC Neurol; 2011 Oct; 11():134. PubMed ID: 22032306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. North Sea Progressive Myoclonus Epilepsy is Exacerbated by Heat, A Phenotype Primarily Associated with Affected Glia.
    Lambrechts RA; Polet SS; Hernandez-Pichardo A; van Ninhuys L; Gorter JA; Grzeschik NA; de Koning-Tijssen MAJ; de Koning TJ; Sibon OCM
    Neuroscience; 2019 Dec; 423():1-11. PubMed ID: 31682953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
    Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
    Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.
    Demir E; Sabatelli P; Allamand V; Ferreiro A; Moghadaszadeh B; Makrelouf M; Topaloglu H; Echenne B; Merlini L; Guicheney P
    Am J Hum Genet; 2002 Jun; 70(6):1446-58. PubMed ID: 11992252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype.
    Scacheri PC; Gillanders EM; Subramony SH; Vedanarayanan V; Crowe CA; Thakore N; Bingler M; Hoffman EP
    Neurology; 2002 Feb; 58(4):593-602. PubMed ID: 11865138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teenage-onset progressive myoclonic epilepsy due to a familial
    van den Ameele J; Jedlickova I; Pristoupilova A; Sieben A; Van Mossevelde S; Ceuterick-de Groote C; Hůlková H; Matej R; Meurs A; Van Broeckhoven C; Berkovic SF; Santens P; Kmoch S; Dermaut B
    Neurology; 2018 Feb; 90(8):e658-e663. PubMed ID: 29352102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
    Barot N; Margiotta M; Nei M; Skidmore C
    Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OS.
    Mazzola L; Oliver KL; Labalme A; Baykan B; Muona M; Joensuu TH; Courage C; Chatron N; Borsani G; Alix E; Ramond F; Touraine R; Bahlo M; Bebek N; Berkovic SF; Lehesjoki AE; Lesca G
    Ann Neurol; 2021 Feb; 89(2):402-407. PubMed ID: 33085104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.